Use this exit readiness checklist to close compliance gaps, document recurring revenue, and position your DME business for a 3.5x–6x EBITDA exit with qualified strategic and SBA-financed buyers.
Selling a medical equipment supply business in the lower middle market requires significantly more preparation than most owner-operators anticipate. Buyers — whether private equity roll-up platforms, regional medical distributors, or SBA-financed entrepreneurs — will scrutinize your Medicare and Medicaid billing history, DMEPOS accreditation status, supplier agreement transferability, and the degree to which the business can operate without you. Regulatory exposure and owner dependency are the two most common deal-killers in this sector, and both are correctable with 12–24 months of focused preparation. This checklist walks you through the three phases of exit readiness: financial and compliance clean-up, operational documentation, and go-to-market preparation. Completing each phase systematically can meaningfully increase your valuation multiple and reduce time on market.
Get Your Free Medical Equipment Supplier Exit ScoreRestate or reformat three years of accrual-based financial statements
Many owner-operated DME businesses run on cash-basis accounting and commingle personal expenses. Restate three full years of financials on an accrual basis and work with your accountant to clearly segment revenue by category: rental income, service contracts, direct equipment sales, and Medicare/Medicaid versus commercial versus private-pay. Buyers will immediately normalize your financials to calculate EBITDA, and unclear or mixed records invite downward adjustments and extended due diligence timelines.
Conduct an internal Medicare and Medicaid billing compliance audit
Hire a healthcare compliance consultant or billing specialist to audit your last three years of Medicare and Medicaid claims for documentation gaps, coding errors, overpayments, and any denial patterns. Buyers and their attorneys will request a full billing compliance history, and undisclosed audit exposure — even minor — can kill deals or trigger material escrow holdbacks. Remediate any identified issues before going to market and document the corrective actions taken.
Verify and document all active regulatory licenses, accreditations, and provider numbers
Compile a complete inventory of your DMEPOS accreditation status, Medicare and Medicaid supplier numbers, state DME licenses, FDA registration if applicable, and any specialty accreditations such as ACHC or The Joint Commission. Confirm expiration dates, renewal schedules, and — critically — whether each credential is transferable to a new owner entity or requires reapplication. Buyers will not close on a business where accreditation continuity is uncertain, as re-accreditation can take six to twelve months and interrupt billing.
Identify and remove personal expenses from the business P&L
Owner vehicles, personal insurance premiums, family payroll, travel, and other discretionary expenses embedded in the income statement obscure your true EBITDA. Work with your accountant to build a clean add-back schedule with supporting documentation for each item. Buyers and lenders — especially SBA lenders underwriting a 7(a) loan — will challenge undocumented add-backs, and poorly supported adjustments reduce the lendable value of the business.
Prepare an inventory valuation report with aging analysis
Commission or internally prepare a current inventory report that categorizes stock by age, product type, and sales velocity. Flag any items older than 18–24 months, discontinued device models, or equipment subject to pending FDA or manufacturer recalls. Medical technology cycles are short and buyers will apply significant haircuts to aging inventory. Proactively liquidating obsolete stock and refreshing the inventory mix before going to market improves balance sheet presentation and reduces due diligence friction.
Document all supplier and distribution agreements with transferability analysis
Pull every active supplier contract, distribution agreement, group purchasing organization membership, and manufacturer authorization letter. For each agreement, identify the contract term, renewal date, exclusivity provisions, and whether assignment to a new owner requires supplier consent. Exclusive or preferred distribution agreements with nationally recognized medical brands are significant value drivers — ensure these are highlighted and that consent to assign can be obtained. Missing or expiring supplier agreements discovered during due diligence are common causes of renegotiated deal terms.
Build a documented customer and referral source database
Create a structured database of all active customers — hospitals, outpatient clinics, physician practices, home health agencies, and individual patients — with associated revenue history for the past three years. Separately document your referral sources such as discharge planners, case managers, and physicians with referral volume and tenure. Demonstrate that no single customer accounts for more than 20–25% of revenue. This directly addresses buyer concern over customer concentration and proves that relationships are institutional, not solely dependent on the owner.
Develop written standard operating procedures for all core business functions
Document the processes governing order intake, insurance verification, prior authorization, delivery and setup, billing and collections, equipment maintenance and cleaning, and compliance reporting. SOPs do not need to be elaborate — clear, step-by-step written procedures that a competent employee can follow without owner involvement are sufficient. Buyers need confidence that operations will continue smoothly post-closing without the seller present, and lenders require evidence of a functional business system beyond one key person.
Build or formalize your management and staff organizational structure
Prepare an org chart that clearly shows reporting lines, roles, and tenure for all key employees including operations managers, billing and reimbursement staff, delivery and service technicians, and sales or account management personnel. If the business currently operates with you handling referral relationships, billing oversight, or supplier negotiations, begin transitioning those responsibilities to identified employees with documented handoff plans. Buyers — particularly PE firms — will pay a premium for a business that already has depth below the owner level.
Quantify and document your recurring revenue base
Isolate and clearly present the proportion of annual revenue derived from equipment rental agreements, service and maintenance contracts, and ongoing supply replenishment relationships versus one-time equipment sales. Prepare a revenue quality schedule showing monthly recurring revenue, contract durations, renewal rates, and churn history. Buyers in this sector assign materially higher multiples to businesses with 40%+ recurring revenue because it reduces post-acquisition cash flow volatility.
Assess and begin reducing owner-dependent referral relationships
Identify physician relationships, hospital discharge planner contacts, and key referral sources that are tied to your personal relationships rather than the business brand or staff relationships. Begin introducing a key employee or account manager to these contacts while you are still present. Consider whether non-solicitation or non-compete provisions with referral sources are documented where appropriate. Buyers will directly ask how referral volume would be retained if the seller departed within 90 days of closing.
Engage a healthcare-specialized M&A advisor or business broker
Select an intermediary with demonstrated experience selling DME, home health, or healthcare services businesses in the lower middle market — not a generalist commercial broker. A specialized advisor will understand how to position DMEPOS accreditation, Medicare billing compliance, and recurring revenue in your confidential information memorandum, and will have access to the strategic acquirers, PE-backed platforms, and SBA-qualified buyers who are actively acquiring in this sector. Request references from past healthcare transactions with deal values between $1M and $10M.
Prepare a formal transition plan for regulatory continuity
Draft a written transition plan that addresses how your DMEPOS accreditation, Medicare supplier numbers, state licenses, and key supplier authorizations will be maintained through and after closing. Include timelines for any reapplication processes that may be required under a new ownership entity. Engage your accreditation body — ACHC or BOC — early to understand assignment versus reapplication requirements. Buyers and their counsel will require this before signing a letter of intent.
Prepare a confidential information memorandum that leads with recurring revenue and compliance strengths
Work with your advisor to develop a CIM that leads with your recurring revenue mix, clean compliance history, accreditation status, and diversified referral base. Include a clear payer mix breakdown showing Medicare, Medicaid, commercial insurance, and private pay percentages. Highlight any exclusive supplier relationships and geographic service area density. Buyers in this sector are specifically screening for regulatory exposure and revenue quality before requesting further diligence, so the CIM must address these concerns proactively.
Structure your deal preferences before fielding offers
Before going to market, work with your M&A advisor and transaction attorney to determine your preferences on deal structure: asset versus stock sale, acceptable earnout provisions tied to contract retention or reimbursement continuity, willingness to carry a seller note for 5–10% of deal value to facilitate SBA financing, and whether you are open to an equity rollover with 10–20% retained stake during a transition period. Having clear, pre-established positions prevents you from making reactive decisions under offer pressure that can cost you significant value.
Conduct a pre-sale quality of earnings review
Commission a buy-side style quality of earnings analysis from an accounting firm experienced in healthcare transactions. The QoE will independently validate your EBITDA, normalize add-backs, review revenue quality, and identify any financial reporting issues before buyers and their advisors discover them. Presenting a seller-sponsored QoE alongside your CIM signals seller sophistication, shortens buyer due diligence timelines, and gives institutional buyers and PE firms the financial confidence to submit full-value offers without aggressive contingency discounts.
See What Your Medical Equipment Supplier Business Is Worth
Free exit score, valuation range, and personalized action plan — 5 minutes.
Most DME and medical equipment supply businesses take 12 to 24 months from the start of exit preparation to a completed closing. The preparation phase — cleaning up financials, addressing compliance gaps, and documenting operations — typically takes 12 to 18 months. Once the business is actively marketed, a well-prepared DME business typically receives qualified letters of intent within 60 to 90 days, followed by a 60 to 120 day due diligence and closing process. Businesses with unresolved Medicare audit exposure, owner-dependent referral relationships, or unclear accreditation transferability frequently experience extended timelines or failed deals.
Medical equipment suppliers in the lower middle market typically sell for 3.5x to 6.0x trailing twelve-month EBITDA. Businesses at the lower end of this range tend to have heavy transaction-based revenue, significant owner dependency, customer concentration, or compliance questions. Businesses achieving 5x to 6x multiples typically demonstrate 40% or more recurring rental and service contract revenue, clean Medicare and Medicaid billing histories, active transferable DMEPOS accreditation, diversified referral bases, and management teams capable of operating independently. The difference between a 4x and a 5.5x multiple on $400,000 EBITDA is $600,000 in additional proceeds — making exit preparation one of the highest-return investments an owner can make.
No — and this is one of the most critical issues to resolve before going to market. DMEPOS accreditation through bodies such as ACHC or BOC is typically tied to the legal entity and ownership structure of the accredited supplier. In most cases, a change of ownership — especially under an asset purchase structure — requires the new owner to apply for new accreditation rather than assume the existing credential. This process can take six to twelve months, during which the new owner may be unable to bill Medicare. Some buyers will structure transactions to preserve the existing entity to maintain accreditation continuity. You should contact your accreditation body and a healthcare transactions attorney at least 12 months before your target sale date to map out the specific transfer or reapplication pathway.
Buyers treat billing compliance as one of the highest-risk areas in any DME acquisition. During due diligence, buyers and their attorneys will typically request three to five years of Medicare and Medicaid billing records, denial and recoupment history, any correspondence with CMS or state Medicaid agencies, results of any prior audits or RAC reviews, and documentation of your compliance program. Even technical billing errors or patterns of documentation deficiencies — not just intentional fraud — can trigger escrow holdbacks, indemnification demands, or deal restructuring. Sellers who commission an internal compliance audit before going to market, remediate identified issues, and present clean findings are significantly more attractive to buyers and face far less post-closing indemnification exposure.
Yes — SBA 7(a) loans are commonly used to finance medical equipment supply acquisitions in the $1M to $5M revenue range, and the SBA eligibility of your business directly shapes how you should prepare. SBA lenders require two to three years of business tax returns, a debt service coverage ratio typically above 1.25x, and a clear verification that the business's cash flow can support loan repayment. Personal expenses mixed into the P&L, unclear EBITDA, or unresolved compliance issues will disqualify or significantly reduce the loan amount a buyer can obtain, which compresses the price they can pay. Sellers who want to maximize buyer pool and achieve full asking price should prepare financials and compliance documentation to a standard that will pass SBA lender underwriting — not just satisfy initial buyer interest.
Customer concentration is one of the most common value-reducing factors in DME business sales. If a single customer accounts for more than 25% of your revenue, most institutional buyers and PE platforms will either pass on the deal, require a significant earnout tied to post-closing customer retention, or apply a meaningful discount to the purchase price to compensate for the risk. The practical solution is to begin diversifying your customer and referral base at least 18 to 24 months before going to market. Adding new referral relationships — with home health agencies, independent physician practices, outpatient surgery centers, or new hospital system discharge planners — and documenting consistent revenue from those new sources over two to three quarters materially reduces the concentration risk discount buyers will apply.
Earnouts are common in DME acquisitions when there is uncertainty around the retention of key supplier agreements, reimbursement approvals under new ownership, or referral relationship continuity post-closing. Typical earnout structures in this sector tie a portion of the purchase price — often 10% to 20% of total consideration — to the business achieving agreed revenue or EBITDA targets over 12 to 24 months post-close, or to the successful transfer of specific Medicare provider numbers or supplier contracts. From a seller's perspective, earnouts represent deferred and contingent value, so the goal during exit preparation is to minimize the buyer's perceived risk so that more of the purchase price can be delivered at closing. Businesses with documented operational independence, transferable accreditations, and diversified customer bases face significantly smaller earnout demands.
More Medical Equipment Supplier Seller Guides
More Exit Checklists
Get your Medical Equipment Supplier exit score, estimated valuation, and a step-by-step action plan — free, in 5 minutes.
Start Your Free Exit AssessmentFree forever · No broker needed · Takes 5 minutes
For Buyers
For Sellers